Léa Hoisnard
Impact in
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
Papers in
-
- Rheumatoid Arthritis Research and Therapies 2
- Genetics 3
- Chronic Lymphocytic Leukemia Research 2
- Co-authors
- Mahmoud Zureik (11 shared papers)É. Sbidian (11 shared papers)Alain Weill (7 shared papers)Laura Pina Vegas (2 shared papers)Rosemary Dray‐Spira (2 shared papers)Lise Duranteau (4 shared papers)Sebastien C. Froelich (4 shared papers)Pascal Claudepierre (2 shared papers)
- Journals
- RMD Open (2 papers)Transplant International (2 papers)Scientific Reports (2 papers)European Journal of Neurology (2 papers)BMJ (1 paper)
- Partner nations
- FranceAustriaSwitzerland
In The Last Decade
Léa Hoisnard
18 papers receiving 420 citations
Léa Hoisnard's Hit Papers
Peers
Comparison fields: 5 of 63
- Rheumatology 116
- Transplantation 9
- Dermatology 30
- Immunology 62
- Epidemiology 94
Countries citing papers authored by Léa Hoisnard
This map shows the geographic impact of Léa Hoisnard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Léa Hoisnard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Léa Hoisnard more than expected).
Fields of papers citing papers by Léa Hoisnard
This network shows the impact of papers produced by Léa Hoisnard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Léa Hoisnard. The network helps show where Léa Hoisnard may publish in the future.
Co-authors
The 25 scholars most cited alongside Léa Hoisnard, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database Hit paper breakdown → | 2022 | 127 |
| 2 | 2022 | 96 | |
| 3 | 2022 | 44 | |
| 4 | 2024 | 44 | |
| 5 | 2024 | 17 | |
| 6 | 2022 | 14 | |
| 7 | 2024 | 14 | |
| 8 | 2022 | 11 | |
| 9 | 2024 | 10 | |
| 10 | 2018 | 9 | |
| 11 | 2022 | 9 | |
| 12 | 2024 | 7 | |
| 13 | 2024 | 7 | |
| 14 | 2023 | 5 | |
| 15 | 2023 | 4 | |
| 16 | 2024 | 3 | |
| 17 | 2024 | 2 | |
| 18 | 2021 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Léa Hoisnard
Léa Hoisnard is a scholar working on Rheumatology, Genetics, Epidemiology, Toxicology and Immunology, having authored 20 papers that have together received 424 indexed citations. Recurring topics across this work include Meningioma and schwannoma management (4 papers), Biosimilars and Bioanalytical Methods (4 papers), Pneumocystis jirovecii pneumonia detection and treatment (2 papers), Pharmacovigilance and Adverse Drug Reactions (2 papers), Autoimmune Bullous Skin Diseases (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Drug-Induced Adverse Reactions (2 papers) and Rheumatoid Arthritis Research and Therapies (2 papers). The work is most often cited by research in Rheumatology (116 citations), Transplantation (9 citations), Dermatology (30 citations), Immunology (62 citations) and Epidemiology (94 citations). Léa Hoisnard has collaborated with scholars based in France, Austria and Switzerland. Frequent co-authors include Mahmoud Zureik, É. Sbidian, Alain Weill, Laura Pina Vegas, Rosemary Dray‐Spira, Lise Duranteau, Sebastien C. Froelich, Pascal Claudepierre, Philippe Grimbert and Lydia Roy. Their work appears in journals such as RMD Open, Transplant International, Scientific Reports, European Journal of Neurology and BMJ.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.